Hemodialysis Market 2028 By Type, Product and service, End user and Geography | The Insight Partners

report image

Hemodialysis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Conventional (3 times per week), Daily (6 days a week), Nocturnal (3-6 nights per week)); Product and service (Equipment, Consumable, Drug, Service); End user (In-center dialysis, Home dialysis) and Geography

Report Code: TIPRE00024406 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming


Hemodialysis is a process of purifying a person's blood whose kidneys are not working normally by using an artificial membrane for waste removal from the blood, restoring the proper balance of electrolytes in the blood, and eliminating extra fluid from the body. Hemodialysis functions are similar to an artificial kidney. The process of filtration and removal is performed by the hemodialyzer. It filters out toxins and removes excess fluid from the blood. There are various types of hemodialysis, such as in-center hemodialysis, home hemodialysis, and daily home hemodialysis.


The "Global Hemodialysis Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the hemodialysis market with detailed market segmentation by type, product and service, end user, and geography. The report provides key statistics on the market status of the leading hemodialysis market players and offers key trends and opportunities in the market.


  •  Based on type, the global hemodialysis market is segmented into conventional (3 times per week), daily (6 days a week), and nocturnal (3-6 nights per week).
  •  Based on product and service, the market is segmented into equipment, consumable, drug, and service.
  •  On the basis of end-users, the market is bifurcated into in-center dialysis and home dialysis.



  •  Rise in incidence of hypertension and diabetes.
  •  Increase in the number of end-stage renal disorder (ESRD) patients.
  •  Lack of kidneys availability for transplants.
  •  Growing funding for improved dialysis products and services.


  •  Numerous product recalls.
  •  Complications and risks associated with dialysis.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The hemodialysis market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the hemodialysis market in these regions.


COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has initially affected the hemodialysis market growth due to the lockdown situation in various countries that caused the delay in diagnosis and treatments to prevent the spread of the virus, which led to a reduction in hospital visits. The pandemic has affected hemodialysis procedures, as people suffering from illnesses, such as acute kidney injury, hypertension, and diabetes, were expected to experience a higher fatality rate, and the people hospitalized with COVID-19 were at significant risk of chronic kidney disease. Therefore, the increasing incidences of kidney failure and chronic renal dysfunction due to COVID-19 were anticipated to promote market growth. Also, the removal of restrictive and the continuation of therapeutic procedures will help the market to grow in the future.

Get more information on this report :


The report covers key developments in the hemodialysis market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from hemodialysis market are anticipated to have lucrative growth opportunities in the future with the rising demand for hemodialysis in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the hemodialysis market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Asahi Kasei Corporation
  •  Fresenius Medical Care AG & Co. KGaA
  •  B. Braun Melsungen AG
  •  Baxter International, Inc.
  •  DaVita, Inc.
  •  Diaverum
  •  Cantel Medical Corp.
  •  Nipro Corporation
  •  Nikkiso Co., Ltd.
  •  NxStage Medical, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Asahi Kasei Corporation
2. Fresenius Medical Care AG and Co. KGaA
3. B. Braun Melsungen AG
4. Baxter International, Inc.
5. DaVita, Inc.
6. Diaverum
7. Cantel Medical Corp.
8. Nipro Corporation
9. Nikkiso Co., Ltd.
10. NxStage Medical, Inc.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount